Literature DB >> 15592804

Novel germline mutation in the transmembrane region of RET gene close to Cys634Ser mutation associated with MEN 2A syndrome.

M Poturnajova1, V Altanerova, L Kostalova, J Breza, C Altaner.   

Abstract

Two mutations on the same allele of RET gene were revealed in a family with predisposition to multiple endocrine neoplasia (MEN) type 2A. The first mutation changes codon 634 from cysteine to serine. The second, a novel mutation in codon 641, changes alanine to serine in the transmembrane domain of the RET protein. Two mutations were present in close proximity in both the patients' germline and tumor DNA and were absent in DNA isolated from healthy family members and control blood donors. All MEN 2A affected family members suffered from medullary thyroid carcinoma and two of ten patients for pheochromocytoma. No parathyroid gland alterations were observed in patients with two RET gene mutations. Analysis of four genetic polymorphisms in the RET gene showed higher incidence of polymorphisms of exons 11 and 15. The observed allelic imbalance in favor of mutated allele in pheochromocytoma corresponded to higher expression of the RET gene. These observations confirm the multifactorial process leading to development of MEN 2A syndrome.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15592804     DOI: 10.1007/s00109-004-0604-6

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  20 in total

1.  Amplification and overexpression of mutant RET in multiple endocrine neoplasia type 2-associated medullary thyroid carcinoma.

Authors:  Steve C Huang; Joshua Torres-Cruz; Svetlana D Pack; Christian A Koch; Alexander O Vortmeyer; Poonam Mannan; Irina A Lubensky; Robert F Gagel; Zhengping Zhuang
Journal:  J Clin Endocrinol Metab       Date:  2003-01       Impact factor: 5.958

2.  Risk and penetrance of primary hyperparathyroidism in multiple endocrine neoplasia type 2A families with mutations at codon 634 of the RET proto-oncogene. Groupe D'etude des Tumeurs à Calcitonine.

Authors:  I Schuffenecker; M Virally-Monod; R Brohet; D Goldgar; B Conte-Devolx; L Leclerc; O Chabre; A Boneu; J Caron; C Houdent; E Modigliani; V Rohmer; M Schlumberger; C Eng; P J Guillausseau; G M Lenoir
Journal:  J Clin Endocrinol Metab       Date:  1998-02       Impact factor: 5.958

3.  Genome-wide copy number imbalances identified in familial and sporadic medullary thyroid carcinoma.

Authors:  Deborah J Marsh; George Theodosopoulos; Klaus Martin-Schulte; Anne-Louise Richardson; Jeanette Philips; Hans-Dietrich Röher; Leigh Delbridge; Bruce G Robinson
Journal:  J Clin Endocrinol Metab       Date:  2003-04       Impact factor: 5.958

4.  A novel case of multiple endocrine neoplasia type 2A associated with two de novo mutations of the RET protooncogene.

Authors:  A Tessitore; A A Sinisi; D Pasquali; M Cardone; D Vitale; A Bellastella; V Colantuoni
Journal:  J Clin Endocrinol Metab       Date:  1999-10       Impact factor: 5.958

Review 5.  Multiple endocrine neoplasia type 2 and RET: from neoplasia to neurogenesis.

Authors:  J R Hansford; L M Mulligan
Journal:  J Med Genet       Date:  2000-11       Impact factor: 6.318

6.  Germline mutation of the RET proto-oncogene in members of Slovak families with multiple endocrine neoplasia 2.

Authors:  M Poturnajova; V Altanerov; R Kettmann; S Feikova; K Hlubinova; I Balazovjech; J Breza; G Fodo; J Knotek; J Matoska; M Podobov; C Altaner
Journal:  Neoplasma       Date:  2001       Impact factor: 2.575

7.  The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis.

Authors:  C Eng; D Clayton; I Schuffenecker; G Lenoir; G Cote; R F Gagel; H K van Amstel; C J Lips; I Nishisho; S I Takai; D J Marsh; B G Robinson; K Frank-Raue; F Raue; F Xue; W W Noll; C Romei; F Pacini; M Fink; B Niederle; J Zedenius; M Nordenskjöld; P Komminoth; G N Hendy; L M Mulligan
Journal:  JAMA       Date:  1996-11-20       Impact factor: 56.272

8.  Genotype-phenotype correlation in multiple endocrine neoplasia type 2: report of the International RET Mutation Consortium.

Authors:  L M Mulligan; D J Marsh; B G Robinson; I Schuffenecker; J Zedenius; C J Lips; R F Gagel; S I Takai; W W Noll; M Fink
Journal:  J Intern Med       Date:  1995-10       Impact factor: 8.989

9.  Early diagnosis of medullary thyroid carcinoma in a 13 years old girl.

Authors:  Z Misíková; L Kostálová; S Podaná; J Knotek; A Caradská
Journal:  Neoplasma       Date:  1995       Impact factor: 2.575

10.  Genotype-phenotype correlation of patients with multiple endocrine neoplasia type 2 in Japan.

Authors:  S Egawa; H Futami; K Takasaki; M Iihara; T Okamoto; M Kanbe; T Ohi; Y Saio; A Miyauchi; Y Takiyama; M Koga; K Miyanaga; K Inoue; S Mitsuyama; Y Nomura; H Takei; S Mugiya; O Ishida; F Zeze; S Shakutsui; H Inoue; H Oya; A Yoshimura; S Ishizuka; K Yamaguchi
Journal:  Jpn J Clin Oncol       Date:  1998-10       Impact factor: 3.019

View more
  5 in total

Review 1.  Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma.

Authors:  Samuel A Wells; Sylvia L Asa; Henning Dralle; Rossella Elisei; Douglas B Evans; Robert F Gagel; Nancy Lee; Andreas Machens; Jeffrey F Moley; Furio Pacini; Friedhelm Raue; Karin Frank-Raue; Bruce Robinson; M Sara Rosenthal; Massimo Santoro; Martin Schlumberger; Manisha Shah; Steven G Waguespack
Journal:  Thyroid       Date:  2015-06       Impact factor: 6.568

2.  Tandem Germline RET Mutations in a Family Pathogenetic for Multiple Endocrine Neoplasia 2B, Confirmed by a Natural Experiment.

Authors:  Minoru Kihara; Akira Miyauchi; Hiroshi Yoshida; Osamu Yamada; Hiroo Masuoka; Tomonori Yabuta; Takuya Higashiyama; Mitsuhiro Fukushima; Yasuhiro Ito; Kaoru Kobayashi; Akihiro Miya
Journal:  Eur Thyroid J       Date:  2014-12-03

3.  RET germline mutations identified by exome sequencing in a Chinese multiple endocrine neoplasia type 2A/familial medullary thyroid carcinoma family.

Authors:  Xiao-Ping Qi; Ju-Ming Ma; Zhen-Fang Du; Rong-Biao Ying; Jun Fei; Hang-Yang Jin; Jian-Shan Han; Jin-Quan Wang; Xiao-Ling Chen; Chun-Yue Chen; Wen-Ting Liu; Jia-Jun Lu; Jian-Guo Zhang; Xian-Ning Zhang
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

4.  Different RET gene mutation-induced multiple endocrine neoplasia type 2A in 3 Chinese families.

Authors:  Qiuli Liu; Dali Tong; Wenqiang Yuan; Gaolei Liu; Gang Yuan; Weihua Lan; Dianzheng Zhang; Jun Zhang; Zaoming Huang; Yao Zhang; Jun Jiang
Journal:  Medicine (Baltimore)       Date:  2017-01       Impact factor: 1.889

5.  The synergy of germline C634Y and V292M RET mutations in a northern Chinese family with multiple endocrine neoplasia type 2A.

Authors:  Zheng Yang; Xinmeng Qi; Neil Gross; Xiujuan Kou; Yunlong Bai; Yaru Feng; Bochun Wang; Mark E Zafereo; Guojun Li; Chuanzheng Sun; Huihui Li; Xiaohong Chen; Zhigang Huang
Journal:  J Cell Mol Med       Date:  2020-09-29       Impact factor: 5.295

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.